NJ

Nukul Jain

Active Director Director DIN 08864487
DIN 08864487 First appointment Sep 2020 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Sep 2020
Shareholding value Locked Premium profile

About Nukul Jain

Nukul Jain has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Diksha Proteins Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08864487
Primary Designation Director
First Appointment 05 Sep 2020
Oldest Company Age 16 yrs

Current companies

Company Designation Appointment Founded Status
Diksha Proteins Private Limited U15142RJ2009PTC029989
Director 05 Sep 2020 2009 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Diksha Proteins Private Limited
Premium access

Shareholding and investment profile for Nukul Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nukul Jain

Nukul Jain has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Diksha Proteins Private Limited. Engaged in General Business. Contributes to corporate operations.

Nukul Jain is associated with 1 company as Director.

Nukul Jain has expertise in General Business.

Nukul Jain has 5 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available